Last reviewed · How we verify
Risk of selected safety events
Risk of selected safety events is a Small molecule drug developed by AstraZeneca. It is currently in Phase 2 development.
At a glance
| Generic name | Risk of selected safety events |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- Pramipexole and the Risk of Serious Adverse Events
- AZD9291 in Combination With Ascending Doses of Novel Therapeutics (PHASE1)
- Southwest Hub for American Indian Youth Suicide Prevention Research (NA)
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications (PHASE3)
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies (PHASE1, PHASE2)
- Safety Action Feedback and Engagement (SAFE) Loop (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Risk of selected safety events CI brief — competitive landscape report
- Risk of selected safety events updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Risk of selected safety events
What is Risk of selected safety events?
Risk of selected safety events is a Small molecule drug developed by AstraZeneca.
Who makes Risk of selected safety events?
Risk of selected safety events is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is Risk of selected safety events in?
Risk of selected safety events is in Phase 2.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: Risk of selected safety events vs similar drugs
- Pricing: Risk of selected safety events cost, discount & access